Publisher： John Wiley & Sons Inc
E-ISSN： 1098-2299|76|6|328-342
ISSN： 0272-4391
Source： DRUG DEVELOPMENT RESEARCH, Vol.76, Iss.6, 2015-09, pp. : 328-342
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Previous Menu Next
Abstract
Related content
Therapeutic Targeting of microRNAs in Cancer: Future Perspectives
DRUG DEVELOPMENT RESEARCH, Vol. 76, Iss. 7, 2015-11 ,pp. :
Access to resources
Recommend
Quality of life in patients with K‐RAS wild‐type colorectal cancer
CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. :
Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. :
Function of mutant and wild‐type plexinB1 in prostate cancer cells
THE PROSTATE, Vol. 73, Iss. 12, 2013-09 ,pp. :
Targeting Prenylated RAS Modifying Enzymes in Cancer Cells
Current Signal Transduction Therapy, Vol. 1, Iss. 3, 2006-09 ,pp. :